Zomedica appoints Anthony K. Blair as COO and Karen DeHaan-Fullerton as Chief Counsel

Zomedica Corp.

Anthony K. Blair appointed COO effective June 13, 2022; base salary $250K with up to 35% annual performance bonus.
Karen DeHaan-Fullerton appointed Chief Counsel and Corporate Secretary; base salary $250K with up to 30% annual bonus.
Blair previously EVP Operations since Jan 2022; prior roles include COO of Cardiox and VP at Neoprobe.
DeHaan-Fullerton had been General Counsel since May 2022; prior experience at Exactech and Elanco.
Both retain previously granted stock options (Blair: 3M shares at $0.35; DeHaan-Fullerton: 500K at $0.24) with four-year vesting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Karen DeHaan-Fullerton

Chief Counsel and Corporate Secretary

ZOMDF · Zomedica Corp.

Effective: 2022-06-13
Filed: June 15, 2022, 7:59 PM ET

On June 13, 2022, the Company appointed Karen DeHaan-Fullerton as the Company’s Chief Counsel and Corporate Secretary.

Appointed

Anthony K. Blair

Chief Operating Officer

ZOMDF · Zomedica Corp.

Effective: 2022-06-13
Filed: June 15, 2022, 7:59 PM ET

On June 13, 2022, Zomedica Corp. (the “Company”) appointed Anthony K. Blair as the Company’s Chief Operating Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Karen DeHaan-Fullerton was appointed as Chief Counsel and Corporate Secretary at Zomedica Corp..

Action: appointed
Role: Chief Counsel and Corporate Secretary

Exact text from the filing

On June 13, 2022, the Company appointed Karen DeHaan-Fullerton as the Company’s Chief Counsel and Corporate Secretary.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Anthony K. Blair was appointed as Chief Operating Officer at Zomedica Corp..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On June 13, 2022, Zomedica Corp. (the “Company”) appointed Anthony K. Blair as the Company’s Chief Operating Officer, effective immediately.

View on SEC.gov

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001654954-22-008381

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.